凝血因子Ⅶ研究进展
摘要
人体血浆凝血因子Ⅶ按分子结构和生物活性可分为两种:以酶原形式存在的因子(FⅦ)和以活化形式存在的因子(FⅦa)。FⅦa作为凝血级联反应的起始酶,在正常生理性与治疗性止血中发挥重要作用,并且与多种出、凝血疾病的发生和进程有关,因而日益受到重视。本文就 FⅦ的生物学功能以及重组活化 FⅦ(rFⅦa)的临床应用等方面的研究进展作一综述。
出处
《国际生物制品学杂志》
CAS
2007年第6期274-278,共5页
International Journal of Biologicals
参考文献24
-
1Bach R, Nemerson Y, Konlgsberg W. Purification and characterization of bovine tissue factor. J Biol Chem, 1981,256( 16): 8324-8331.
-
2Broze GJ, Leykam JE, Schwartz BD, et al. Purification of human brain tissue factor. J Biol Chem, 1985, 260 (20) : 10917- 10920.
-
3Bach R,Gentry R, Nemerson Y. Factor Ⅶ binding to tissue factor in reconstituted phospholipid vesicles:induction of cooperativity by phosphatidylserine. Biochemistry, 1986, 25 (14): 4007-4020.
-
4Nemerson Y,Repke D. Tissue factor accelerates the activation of coagulation factor Ⅶ:the role of a bifunctional coagulation cofactor. Thromb Res, 1985,40 (3) : 351-358.
-
5Rao LV, Rapaport SI. Activation of factor Ⅶ bound to tissue factor:a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci USA, 1988, 85 (18) : 6687- 6691.
-
6Suttie JW. Vitamin K-dependent carboxylase. Annu Rev Biochem, 1985,54 : 459-477.
-
7Pike AC, Brzozowski AM, Roberts SM, et al. Structure of human factor Ⅶa and its implications for the triggering of blood coagulation. Proc Natl Acad Sci USA, 1999, 96 ( 16 ) : 8925- 8930.
-
8Seetharam S, Murphy K, Atkins C, et al. Cloning and expression of rat coagulation factor Ⅶ. Thromb Res, 2003,109 (4): 225-231.
-
9Eigenbrot C. Structure, function, and activation of coagulation factor Ⅶ. Curr Protein Pept Sci,2002,3(3) :287-299.
-
10Warn-Cramer BJ, Rao LV, Maki SL, et al. Modifications of extrinsic pathway inhibitor(EPI)and factor Xa that affect their ability to interact and to inhibit factor Ⅶa/tissue factor: evidence for a two-step model of inhibition. Thromb Haemost, 1988,60(3) :453-456.
二级参考文献80
-
1Bernstein DE, Jeffers L, Erhardtsen E, et al. Recombinant factor Ⅶ a corrects prothrombin time in cirrhotic patients :a preliminary study. Gastroenterology, 1997,113:1930.
-
2Kalicinski P, Kaminski A, Drewniak T, et al. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant factor Ⅶ a .Transplant Proc, 1999,31: 378.
-
3Gerotzizfas GT, Zercas C, Gavrielidis G, et al. Effective hemostasis with recombinant factor Ⅶ a treatment in two patients with severe thrombocytopenia and life-threatening hemorrage.American of Hemat, 2002,69,219.
-
4Shapirl AD,Gklchrist GS, Hoots WK, et al. Prospective, randomized trial of two doses of rFⅦ a (Novo Seven) in hemophilia patients with inhibitors undergoing surgery. Thrombo Haemost, 1998,80 : 773.
-
5Anderson JAM,Cook MK, Ludlam CA. Can factor Ⅶ a alone secure haemostasis in patients with liver cirrhosis? Haemostasis,2000,30(suppl. 1): 178.
-
6Ejiersen E,Melsen T,Ingerslev J, et al. Recombinant activated factor Ⅶ (rFⅦa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices.Scand J Gastroenterol,2001,36:1081.
-
7Hendriks HGD, Meijer K, Dewolf ITM, et al . Detection the influence of recombinant factor Ⅶ a on coagulation by thromboelastography in liver transplantation. Blood coagulation and fibrinolysis,2002,13(4): 309.
-
8Kalicicinnski A, Drewnisk T. Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor Ⅶ. Transplant Proc,1999,31:378.
-
9Gerotziafas GT, Zervas C, Gavrielidis G, et al. Effective hemostasis with rFⅦa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. Am J Hematology,2002,69:219.
-
10Hoffman M, Monroe DM, Robert HR, et al. Activated factor Ⅶ activates factor IX and X on the surface of activated platelets: thought on mechanism of action of high-dose activated factor Ⅶ. Blood Firbol,1998,9(suppl 1) :561.
共引文献18
-
1饶绍琴,杨洋,腾飞鹏,赵清,杨百理,刘华.不同温度和时间对凝血因子Ⅶ的影响[J].实用医院临床杂志,2005,2(2):90-91. 被引量:5
-
2袁栋才,刘秀丽,王晓莉,郭力.脑出血的病理与临床进展[J].医学综述,2006,12(10):633-635. 被引量:9
-
3吕茂民,周华蕾,刘子,章金刚.人凝血因子Ⅶ单克隆抗体的制备与鉴定[J].生物技术通讯,2008,19(1):73-75. 被引量:1
-
4于明哲,张宁.高血压脑出血的治疗进展[J].中国冶金工业医学杂志,2008,25(4):422-423. 被引量:3
-
5鲁俊,李维勤,李宁,聂垚,童智慧,柯路,黎介寿.rFⅦa对重症急性胰腺炎术中凝血功能及出血量影响的临床研究[J].外科理论与实践,2010,15(1):27-29.
-
6王卓,吕茂民,冯晶晶,赵媛媛,章金刚.重组人凝血因子Ⅶ在Flp-In-CHO细胞中的表达及鉴定[J].中国生物制品学杂志,2010,23(3):248-251. 被引量:6
-
7吕茂民,王卓,冯晶晶,章金刚.重组人凝血因子Ⅶ的纯化与鉴定[J].中国输血杂志,2010,23(4):252-255. 被引量:2
-
8凌静娴,胡娅莉,王志群.罕见顽固性产后大出血抢救成功一例[J].中华围产医学杂志,2010,13(4):345-346. 被引量:1
-
9洪彬源,刘洪珍,杨承祥,黄腾,伍辉萍,蔡日生,杨子文.围术期保温对老年患者止血功能的影响[J].国际麻醉学与复苏杂志,2012,33(6):386-391. 被引量:2
-
10袁强,刘华,吴惺,吴雪海,金毅,孙一睿,杜棹婴,高亮,胡锦.重组凝血因子Ⅶa在颅脑创伤中的应用(附三例报告)[J].中华神经外科杂志,2012,28(12):1255-1258.
-
1周立红,刘敏涓,魏文宁,刘泽霖.血浆凝血因子Ⅶ的测定及其广州地区参考值的建立[J].临床检验杂志,2000,18(1):30-31.
-
2孙健,田野,王毅,董信龙,江荣才,张建宁.颅脑创伤的输血治疗进展[J].天津医药,2017,45(3):329-332. 被引量:2
-
3李萍珠,徐炜新,印美娟.脑梗死患者血清细胞间黏附分子-1和凝血因子Ⅶ的水平研究及临床意义[J].检验医学,2009,24(2):131-133. 被引量:1
-
4徐世洲,肖小璞.重组活化的凝血因子Ⅶ与肝脏疾病治疗中的应用[J].中国输血杂志,2006,19(2):152-154.
-
5王学锋,许冠群,璩斌,王鸿利.基因重组活化凝血因子Ⅶ(rF Ⅶa)制品的初步临床应用[J].中国输血杂志,2005,18(1):36-38. 被引量:3
-
6余华,马礼坤,丁晓梅,严激,吴竟生,顾统元.凝血因子在冠心病发病机制中的作用研究[J].临床心电学杂志,2005,14(4):262-266. 被引量:2
-
7张军建,刘艳霞.血清降钙素原检测对于新生儿脓毒血症预后的评估价值[J].中国医疗前沿,2013,8(24):93-93. 被引量:2
-
8江虹,王霞,廖娟,周静,贾劲.血浆凝血因子Ⅱ、Ⅶ活性检测的应用[J].血栓与止血学,2007,13(3):121-123. 被引量:1
-
9李士敏,王鸿利,支立民.缺乏凝血因子Ⅶ基质血浆的制备及在肝病中的应用[J].上海医学检验杂志,1992,7(1):34-35.
-
10李沛,刘宏景.肝病患者不同病型凝血指标的检测结果分析[J].上海医学检验杂志,2001,16(4):224-224. 被引量:15